DONDI, DONATELLA
DONDI, DONATELLA
DIPARTIMENTO DI ENDOCRINOLOGIA, FISIOPATOLOGIA E BIOLOGIA APPLICATA (attivo dal 01/01/2009 al 26/04/2012)
Antiproliferative effect of mifepristone ({RU}486) on human neuroblastoma cells ({SK}-N-{SH}): in vitro and in vivo studies
2020 L.A. Casulari, D. Dondi, G. Pratesi, F. Piva, M. Milani, M. Piccolella, R. Maggi
Dosimetric analysis of phenolic solid state pellets exposed to radio-therapeutic photon and electron beams through electron spin resonance technique=Analisi dosimetrica di composti fenolici irradiati con fasci clinici di fotoni ed elettroni tramite spettroscopia di risonanza di spin elettronico
2018 S. Gallo, G. Iacoviello, S. Panzeca, I. Veronese, D. Dondi, G. Loi, E. Mones, M. Marrale
Effects of caloric restriction and low glycemic index diets associated with metformin on glucose metabolism and cortisol response in overweight/obese subjects: a case series study
2015 L.A. Casulari, D. Dondi, F. Celotti, F.V.P. da Silva, C.E.G. Reis, T.H.M. da Costa
Epigenetic control of pi3k/akt activity in prostate cancer during hormone manipulation
2010 C. Festuccia, G.L. Gravina, D. Dondi, M. Piccolella, M. Ruscica, V. Tombolini, M. Motta
Ozarelix, a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors
2010 C. Festuccia, D. Dondi, M. Piccolella, A. Locatelli, G.L. Gravina, V. Tombolini, M. Motta
Estrogen receptor β and the progression of prostate cancer : role of 5{alpha}-androstane-3β,17β-diol
2010 D. Dondi, M. Piccolella, A. Biserni, S. Della Torre, B. Ramachandran, A. Locatelli, P. Rusmini, D. Sau, D. Caruso, A. Maggi, P. Ciana, A. Poletti
Role of Ozarelix in the control of proliferation, migration and invasion of human prostate cancer cell lines
2008 C. Festuccia, M. Piccolella, A. Locatelli, M. Bologna, M. Motta, D. Dondi
Biologia Cellulare
2008 E. Messi, M.G. Zanisi, A. Poletti, D. Dondi, R.M. Moretti, P. Limonta
suPAR, a soluble form of urokinase plasminogen activator receptor, inhibits human prostate cancer cell growth and invasion
2008 M. Piccolella, C. Festuccia, D. Millimaggi, A. Locatelli, M. Bologna, M. Motta, D. Dondi
Role of estrogen receptor beta in the progression of prostate cancer
2008 D. Dondi, A. Biserni, M. Piccolella, A. Maggi, D. Sau, P. Ciana, A. Poletti
Estrogen receptor beta and the progression of prostate cancer - role of 5alpha-androstane-3beta,17beta-diol (3beta-Adiol)
2008 D. Dondi, M. Piccolella, P. Ciana, A. Maggi, A. Locatelli, M. Motta, D. Sau, A. Poletti
Role of a soluble form of urokinase plasminogen-activator receptor in the control of human prostate cancer cell growth and invasion
2008 M. Piccolella, C. Festuccia, D. Millimaggi, A. Locatelli, M. Bologna, M. Motta, D. Dondi
Antiproliferative action of RU486 on human neuroblastoma cells (SK-N-SH)
2007 D. Dondi, L.A. Casulari, M. Piccolella, G. Pratesi, F. Piva, R. Maggi
Cellular mechanisms regulating uPA in hormone refractory prostate cancer : role of suPAR, a solubile form of Urokinase Plasminogen-Activator Receptor
2007 M. Piccolella, C. Festuccia, D. Millimaggi, A. Locatelli, M. Bologna, M. Motta, D. Dondi
GnRH analogues inhibit the plasminogen activator system and the metastatic progression of prostate cancer
2006 M. Piccolella, C. Festuccia, M. Bologna, M. Motta, D. Dondi
Role of GnRH analogs in the control of the plasminogen activator system in human prostate cancer cell lines
2006 D. Dondi, M. Piccolella, C. Festuccia, M. Bologna, M. Motta
Role of Estrogen Receptor beta on prostate cancer cell migration
2006 D. Sau, V. Guerini, D. Dondi, P. Ciana, A. Maggi, M. Motta, A. Poletti
Role of estrogen receptor β in the pathogenesis and progression of prostate cancer
2006 D. Dondi, D. Sau, M. Piccolella, M. Tortoreto, G. Pratesi, P. Ciana, A. Maggi, V. Guerini, M. Motta, A. Poletti
Expression and role of glucocorticoid receptors in mouse neurons secretine gonadotropin releasing hormons
2006 F. Piva, M. Piccolella, E. Messi, M. Demisie, A. Cariboni, S. Selleri, A. Samara, G. Consalez, R. Maggi, D. Dondi
GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system
2006 D. Dondi, C. Festuccia, M. Piccolella, M. Bologna, M. Motta